Found: 3
Select item for more details and to access through your institution.
Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
- Published in:
- Oncologist, 2015, v. 20, n. 6, p. 615, doi. 10.1634/theoncologist.2015-0106
- By:
- Publication type:
- Article
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECOG 3204
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 8, p. 1521, doi. 10.1002/cncr.27890
- By:
- Publication type:
- Article